top of page
Preclinical Sarcopenia and Muscle Wasting Models
Sarcopenia is characterized by progressive loss of skeletal muscle mass, strength, and functional capacity, often associated with aging, metabolic dysfunction, frailty, and reduced mobility.
​
IPS Therapeutique offers mouse and rat models of sarcopenia and muscle wasting to evaluate therapies targeting muscle function, muscle mass, tissue remodeling, and metabolic contributors to skeletal muscle decline.
​
These models support assessment of grip strength, functional performance, muscle weight, blood biomarkers, and skeletal muscle histology.
bottom of page